In addition, SECTM1 expression was positively correlated with neoantigen burden and tumor mutation burden (TMB) in the IMvigor210 and GSE176307 cohorts, respectively (Figures S3D–S3F). The gene discussed is SECTM1; the disease is neoplasm.